Attached files
Exhibit 10.2
Confidential
EMPLOYMENT AGREEMENT
This Employment Agreement (this Agreement), dated as of May 4, 2020, is entered into by and between Steven J. Sell (the Executive), Agilon Health Topco, Inc., a Delaware corporation (Parent), and agilon health, inc., a Delaware corporation and wholly-owned subsidiary of Parent (the Company).
W I T N E S S E T H:
WHEREAS, Parent and the Company desire to employ the Executive as their Chief Executive Officer and for the Executive to serve as a member of the Board of Directors of Parent (the Board), and the Executive desires to provide services to Parent and the Company in such capacities, in each case pursuant to the terms and conditions set forth in this Agreement.
NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein, and intending to be legally bound hereby, the parties hereto agree as follows:
1. | Nature of Employment |
Subject to Section 3, effective as of the Effective Date (as defined below) and continuing during the Term of Employment, Parent and the Company shall employ the Executive, and the Executive agrees to accept employment, as the Chief Executive Officer of Parent and the Company and in such positions to undertake the duties and responsibilities commensurate with such positions and as may be reasonably assigned to the Executive from time to time by the Board. During the Term of Employment (as defined below), the Executive shall report directly to the Board and shall serve as a member of the Board.
2. | Extent of Employment |
(a) During the Term of Employment, the Executive shall perform his obligations hereunder faithfully and to the best of his ability at the place of employment provided in Section 2(d), under the direction of the Board, and shall abide by the policies from time to time established by the Company.
(b) During the Term of Employment, the Executive shall devote all of his business time, energy and skill as may be reasonably necessary for the performance of his duties, responsibilities and obligations hereunder (except for vacation periods and reasonable periods of illness or other incapacity).
1
(c) The Executive may continue to maintain his Approved Outside Interests (as defined below), unless such interests or relationships conflict or interfere with Parents and the Companys business or the Executives position at Parent and the Company. In addition, the Executive may serve on civic or charitable boards or committees, unless the Board notifies the Executive that, in the Boards discretion, such civic or charitable positions interfere with the Executives position at Parent and the Company or his obligations pursuant to this Agreement.
(d) Except as set forth on Exhibit A hereto (the Approved Outside Interests), as of the date hereof, the Executive does not have any ownership interests (other than ownership of less than 1% of the outstanding stock of a publicly-traded company) or professional relationships with (whether as an employee, director, officer, consultant or advisor, and whether or not for compensation) or professional commitments to any person or entity other than Parent and its subsidiaries. After the date hereof, if approved by the Board (or the Chairman of the Board), the Executive may acquire ownership interests of, or engage in professional relationships (whether as an employee, director, officer, consultant or advisor, and whether or not for compensation) with or have professional commitments to, a person or entity other than Parent and its subsidiaries.
(e) During the Term of Employment, the principal place of Executives employment shall be at the Companys office in Long Beach, California, subject to customary business travel on the business of the Company and its affiliates.
3. | Term of Employment; Termination |
(a) The Term of Employment shall commence on June 1, 2020 or such other date mutually agreed in writing between the Executive and the Chairman of the Board (the Effective Date) and shall continue until the Executives employment is terminated by the Company pursuant to Section 3(b) or by the Executive pursuant to Section 3(c).
(b) Subject to the payments contemplated by Section 3(f), the Executives employment may be terminated at any time by the Company:
(i) upon the death of the Executive;
(ii) in the event that, because of physical or mental disability, the Executive is unable to perform, and does not perform, in the opinion of the Board and as certified in writing by a competent medical physician selected by the mutual agreement of the Company and the Executive or his legal representative, his duties hereunder for a period of 180 days out of any 270-day period (Disability);
(iii) for Cause; or
(iv) for any other reason or no reason, it being understood that no reason shall be required for termination of the Executives employment.
2
The Executive acknowledges that nothing contained herein or otherwise stated by or on behalf of Parent or the Company modifies or amends the right of the Company to terminate the Executive at any time, with or without Cause. The Executives termination shall become effective upon death or the delivery by the Company to the Executive of notice specifying such termination and the reasons therefor (i.e., Sections 3(b)(ii) - (iv)) subject to any requirement for advance notice in the case of a termination for Cause and an opportunity to cure provided in this Agreement, if and to the extent applicable.
(c) Subject to the payments contemplated by Section 3(f), the Executives employment may be terminated at any time by the Executive:
(i) upon the death of the Executive;
(ii) in the event of Disability;
(iii) for Good Reason; or
(iv) for any other reason or no reason (a Voluntary Termination).
The Executives termination shall become effective upon death or, in the case of Disability, the delivery by the Executive to the Board of notice specifying such termination. Any other termination by the Executive shall require at least 60 days prior written notice to the Board (unless waived in writing by the Board) and, in the case of a termination by the Executive for Good Reason, an opportunity to cure provided in this Agreement, if and to the extent applicable.
(d) As used in this Agreement, Cause shall mean any of the following:
(i) the Executives commission of a crime involving moral turpitude, embezzlement, fraud, conversion of property or false statements or other similar acts or any other felony;
(ii) the Executives gross negligence, continued willful failure or breach (other than by reason of death or Disability) to perform his material duties for Parent, the Company or any of their subsidiaries;
(iii) the Executives violation of a material provision of any written Parent, Company or subsidiary policy as in effect from time to time that has been communicated to the Executive, which violation is not cured within 30 days after the Company delivers written notice to the Executive that identifies and describes the alleged violation in reasonable detail (the Cure Period); provided that it shall be presumed that any material breach of the restrictive covenants contained in the Equity Documentation is not capable of being cured for purposes of this definition of Cause;
3
(iv) the Executives material breach of any written agreement with Parent or its subsidiaries, including the Company, to which the Executive is a party or by which the Executive is bound (including, but not limited to, this Agreement and the Equity Documentation (as defined below)), which breach is not cured within the Cure Period; or
(v) the Executives breach of Section 2(c) or (d) or Section 9(b).
For purposes of this Section 3(d), (A) no act or failure to act on the part of the Executive shall be considered willful unless it is done, or omitted to be done, by the Executive in bad faith or without reasonable belief that the Executives action or omission was in the best interests of the Company and (B) any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or upon the advice of counsel for the Company shall be conclusively presumed to be done, or omitted to be done, by the Executive in good faith and in the best interests of the Company
The determination as to whether Cause has occurred shall be made in good faith by the Board. The Board shall have the authority to waive the consequences of the existence or occurrence of any of the events, acts or omissions constituting Cause. Prior to any termination for Cause, the Board must provide written notice to the Executive within the 60 days following the date on which the Board (excluding the Executive) or the Chairman of the Board discovers the alleged Cause event setting forth in reasonable detail the conduct alleged to be a basis for a termination for Cause. The Executive, while serving as a member of the Board, shall take no part in any determination as to whether Cause exists hereunder.
A termination for Cause shall be deemed to include a determination by the Board within 90 days following the Executives Voluntary Termination that circumstances existed prior to such termination for the Company or one of its subsidiaries to have terminated the Executives employment for Cause; provided that in such event the Executive shall first be provided with any applicable cure rights to the extent available; and provided, further, that this sentence shall not apply to any circumstances actually known to the Board (excluding the Executive) or the Chairman of the Board 60 or more days prior to the date of such termination.
(e) As used in this Agreement, Good Reason shall mean any of the following, without the Executives written consent:
(i) a material diminution of the Executives Base Salary from the amount set forth in Section 4(a);
4
(ii) a material diminution of the Executives target annual bonus opportunity, at target performance levels, from the Executives annual bonus opportunity, at target performance levels, during the immediately preceding annual bonus measurement period (it being understood that the actual amount of the annual bonus and performance criteria shall be subject to Section 4(b) and that the Boards decision to award an amount less than the target amount shall not constitute Good Reason);
(iii) a material diminution in the Executives authority, duties or responsibilities as Chief Executive Officer of the Company;
(iv) at any time following the Effective Date but prior to a Change in Control (as defined in the Stock Incentive Plan (as defined below)), a requirement that the Executive report to a corporate officer or employee instead of reporting directly to the Board (or the board of directors (or similar governing body) of any successor to Parent or the Company);
(v) the relocation of the Executives principal place of employment to a location that is not within 50 miles of the Companys office in Long Beach, California; or
(vi) a material breach by the Company or Parent of any written agreement between the Executive, on the one hand, and any of the Parent, Company, or their controlled affiliates or subsidiaries, on the other hand (including, but not limited to, this Agreement and the Equity Documentation).
Notwithstanding the foregoing, the Executive shall not have Good Reason to terminate his employment to the extent that, as a result of a Change in Control or IPO, Executives authority, duties, responsibilities and/or reporting line is conformed to reflect changes to Parent, the Company and their subsidiaries following the transaction, including an integration of their businesses with another business or acquirer.
Prior to any termination for Good Reason, the Executive must provide written notice to the Board (excluding the Executive) within 60 days following the date on which he discovers an alleged Good Reason event setting forth in reasonable detail the conduct alleged to be a basis for a termination for Good Reason. The Executive shall not have the right to terminate his employment for Good Reason (i) if, within the 30-day period following delivery of the Executives written notice, the Company or Parent, as applicable, shall have cured the conduct alleged to be a basis for termination for Good Reason and (ii) absent such cure, unless the Executive actually terminates employment within 45 days following the end of the Companys Cure Period.
(f) The Executive shall be entitled to certain payments upon termination of his employment, as follows:
(i) In the event the Executives employment is terminated for any reason, the Executive shall be entitled to receive (A) his Base Salary through the effective date of
5
termination, (B) any accrued benefits unpaid as of the effective date of termination, (C) any expense reimbursements related to expenses reimbursable hereunder that are incurred through the effective date of termination, (D) any accrued but unpaid vacation (to the extent payable under the applicable law or Company policy) and (E) other benefits required by law to be provided to him after termination of employment, in each case when paid according to the Companys applicable lawful policies and standard practices and the lawful terms of this Agreement (the Base Termination Compensation).
(ii) In the event the Executives employment is terminated by the Company for any reason other than for Cause (and for the avoidance of doubt not death or Disability), or by the Executive for Good Reason (a Qualifying Termination), then the Executive shall be entitled to (A) the Base Termination Compensation, (B) severance pay equal to the sum of (x) the Executives base salary, at the rate in effect at the effective time of termination, to be paid in equal installments over 18 months on the Companys normal payroll dates following the date of termination, plus (y) the Executives target bonus as provided in Section 4(b), to be paid in equal installments over 12 months on the Companys normal payroll dates following the date of termination, except that the first installment of such payment under each of clause (x) and (y) shall be paid on the 60th day following the termination date and shall include all installments that would have been paid if the release of claims referred to in Section 3(i) had been effective at the date of termination, (C) any earned but unpaid annual bonus for the fiscal year prior to the fiscal year in which the Executives termination occurred determined pursuant to Section 4(b), and (D) the continuation of the medical, dental and vision insurance coverage for a period of 12 months at active employee rates (the Benefit Continuation). The Benefit Continuation shall be provided through (x) the Executives enrollment in the Companys COBRA continuation coverage and (y) the reimbursement of (or the Company otherwise bearing) the premium cost under COBRA in excess of the active-employee rate. Any payment of the Executives Base Salary after termination of his employment shall be made in accordance with the Companys regular payroll practices. Because of the current uncertainty surrounding health care coverage, in the event that the Benefit Continuation would subject the Executive or the Company to a material cost, tax or penalty, the parties agree to cooperate to provide the Executive with such benefits in a manner that does not trigger such tax, cost or penalty, to the maximum extent possible (including, for example, making a lump sum payment).
Other than solely in connection with any equity interests of Parent held by the Executive as described in Section 5 and provided in the Equity Documentation, there will be no additional amounts owing by the Company to the Executive from and after a Qualifying Termination.
(iii) If the Executives employment is terminated for Cause, then the Executive shall be entitled to the Base Termination Compensation. Other than solely in connection with any equity interests of Parent held by the Executive (to the extent provided in the Equity Documentation), there will be no additional amounts owing by the Company to the Executive from and after his termination by the Company for Cause.
6
(iv) If the Executives employment is terminated due to a Voluntary Termination, then the Executive shall be entitled to the Base Termination Compensation. Other than solely in connection with any equity interests of Parent held by the Executive (to the extent provided in the Equity Documentation), there will be no additional amounts owing by the Company to the Executive from and after his Voluntary Termination.
(v) If the Executives employment is terminated due to the Executives death or Disability, then the Executive shall be entitled to the Base Termination Compensation and, if terminated due to Disability, the Benefit Continuation. Other than solely in connection with any equity interests of Parent held by the Executive (to the extent provided in the Equity Documentation), there will be no additional amounts owing by the Company to the Executive from and after his termination due to death or Disability.
(g) Termination of the Executives employment will not terminate Sections 3(f) through 3(k) and 8 through 23, or any other provisions not associated specifically with the Term of Employment.
(h) In the event the Executives employment is terminated and the Executive obtains alternative employment and is provided medical coverage in connection therewith, the medical coverage the Company provides pursuant to Section 3(f)(ii) shall be secondary to the medical coverage provided in connection with the alternative employment. Any provision herein to the contrary notwithstanding, if, following his termination of employment, the Executive materially breaches any restrictive covenant contained in the Equity Documentation, or, without the Boards prior written consent, competes with the business of Parent, the Company and their subsidiaries as then conducted, the Company shall have no further payment or benefit obligations under Section 3(f)(ii).
(i) In the event the Executives employment is terminated and the Company is obligated to make payments pursuant to Section 3(f)(ii), other than the Base Termination Compensation, it shall be a condition to such payments that, within 30 days following the date of termination, the Executive enter into a general release of claims, in the form attached hereto as Exhibit B.
(j) The equity interests of Parent held by the Executive on the date of termination or date of death shall be subject to the terms and conditions of the Equity Documentation, including, without limitation, the restriction periods, vesting and forfeiture schedules, and termination and repurchase provisions, subject to Section 5.
(k) Upon termination of the Executives employment for any reason, the Executive shall be deemed to have resigned from all positions with Parent and its affiliates (including, without limitation, any committees that oversee or have fiduciary responsibility for any benefit plan of Parent or its affiliates), including the Company, and, at Parents request, the Executive shall promptly deliver written evidence of such resignation.
7
4. | Compensation |
The Company shall pay compensation to the Executive as follows:
(a) Base Salary. During the Term of Employment, the Company shall pay to the Executive as base compensation for his services hereunder, on the Companys regular payroll dates, a base salary at a rate of not less than $750,000 per annum (Base Salary).
(b) Annual Bonus. For each fiscal year during the Term of Employment, the Executive will be eligible for an annual bonus with a target payment equal to 75% of the Executives Base Salary based on the Executives achievement of pre-established performance goals and conditions, as the Board (or the Compensation Committee of the Board) shall determine on an annual basis (during or before the first quarter of each fiscal year), in accordance with the annual bonus plan adopted by the Board that is applicable to senior management of the Company; provided that for the 2020 fiscal year the Executives bonus will be prorated for the time he is employed by the Company in the 2020 fiscal year.
The actual amount of any bonus paid for any fiscal year shall be determined by the Board (or the Compensation Committee) based on its assessment of the actual performance against such goals against the goals and conditions established for the year, as follows:
Performance Level |
Bonus Amount | |||
Below Threshold |
<75% of target performance | 0% of Executives Base Salary | ||
Threshold |
75% of target performance | 50% of Executives Base Salary | ||
Target |
100% of target performance | 75% of Executives Base Salary | ||
Maximum |
125% or more of target performance | 100% of Executives Base Salary |
In the event that the performance falls between Threshold and Target, or between Target and Maximum, the annual bonus shall be determined by straight-line linear interpolation.
Any annual bonus payable to the Executive for a fiscal year shall be paid to the Executive not later than two and a half months following the end of such fiscal year to which the performance relates. Except as provided in Section 3(f)(ii), it shall be a condition to the payment of any annual bonus that the Executive remain employed through the last day of the applicable fiscal year.
5. | Equity-Based Compensation Subject to the Executive commencing employment on the Effective Date, the Executive shall be provided with the following equity-based compensation, no later than 30 days following the Effective Date, at a time determined by the Board: |
8
(a) Share Purchase. The Executive shall invest at least $1,000,000 in the aggregate in the purchase of fully-vested shares of common stock of Parent, par value $0.01 per share (the Shares), at a per share price of $449. Parents sale of the Shares to the Executive will be made pursuant to the Amended and Restated Agilon Health Topco, Inc. Stock Incentive Plan (as amended, the Stock Incentive Plan). The terms and conditions applicable to the Executives acquisition, holding and disposition of the Shares at the time of such sale shall be set forth in a subscription agreement in the form attached hereto as Exhibit C (the Subscription Agreement).
(b) Stock Options. Parent shall grant the Executive non-qualified options to purchase 55,500 additional Shares under the Stock Incentive Plan (the Options), consisting of the following:
(i) Time-Vesting Base Options. 20,000 Options that will vest in five annual installments at a rate of 20% per year on each of the first five anniversaries of the Effective Date, subject to the continuous employment of the Executive with the Company until the applicable vesting date (the Time-Vesting Base Options). The exercise price per Share covered by the Time-Vesting Base Options shall be $449. In the event of a Change in Control, subject to the Executives continued employment with the Company, all of his then unvested Base Options will immediately vest. None of the Time-Vesting Base Options will vest upon an initial public offering of Parents Shares (an IPO).
(ii) IPO-Vesting Base Options. 10,000 Options that will all vest, subject to the Executives continued employment with the Company, in the event that Parent completes an IPO (IPO-Vesting Base Options). The exercise price per Share covered by the IPO-Vesting Base Options shall be $449.
(iii) Upside Options. 25,000 Options that will vest (x) in five annual installments at a rate of 20% per year on each of the first five anniversaries of the Effective Date, subject to the continuous employment of the Executive with the Company until the applicable vesting date or (y) if earlier, upon a Change in Control, but only if (z) as of such date, investment funds affiliated with Clayton, Dubilier & Rice, LLC shall have actually received cash proceeds from the sale of Shares owned by them equal to at least 3.0 times all of their Aggregate Initial Investment (as defined in the Option Agreement (as defined below) in Parent (the Upside Options). The exercise price per Share covered by the Upside Options shall be $1,011. No vesting of the Upside Options will accelerate upon an IPO.
(iv) The terms and conditions applicable to the Executives acquisition, holding and disposition of the Options shall be set forth in a stock option agreement in the form attached hereto as Exhibit D (the Option Agreement). The Stock Incentive Plan, the Subscription Agreement and the Option Agreement are referred to in this Agreement as the Equity Documentation.
9
6. | Reimbursement of Expenses |
(a) During the Term of Employment, the Company will promptly reimburse the Executive (or pay directly) for reasonable and documented travel, entertainment and other expenses reasonably incurred by the Executive in connection with the performance of his duties hereunder and, in each case, in accordance with the policies, rules, customs and usages promulgated by Parent or the Company and in effect from time to time and applicable law. Any payments due under this Section 6(a) will be payable in accordance with the Companys usual payroll practices.
(b) Legal Fees. The Company shall reimburse the Executive for up to $20,000 of the reasonable legal fees and expenses paid or incurred by the Executive in connection with the negotiation and preparation of this Agreement.
7. | Benefits |
Beginning on the Effective Date and during the Term of Employment, the Executive shall be entitled to participate in and be covered by any insurance plan (including but not limited to medical, dental, health, accident, hospitalization and disability), 401(k), profit sharing or other employee benefit plan of the Company, to the same extent and on substantially the same terms as such benefits are or may be provided by the Company, at the sole discretion of the Board, from time to time to other members of the senior management of the Company, and in all circumstances in accordance with the policies, rules, customs and usages promulgated by the Company and in effect from time to time.
8. | Notice |
Any notice, request, demand or other communication required or permitted to be given under this Agreement shall be given in writing and if delivered by electronic mail, personally, or sent by certified or registered mail, return receipt requested, as follows (or to such other addressee or address as shall be set forth in a notice given in the same manner):
(a) If to the Executive, to the Executive at his Company-provided electronic mail address, or at the address most recently contained in the Companys records (which the Executive shall update as necessary)
with copies (which shall not constitute notice) to:
Wilson Sonsini Goodrich & Rosati
650 Page Mill Road
10
Palo Alto, CA 94304
Attention: David Thomas, Esq.
E-mail: dthomas@wsgr.com
(b) | If to Parent or the Company: |
at the address of the Companys then current headquarters, to the attention of the Companys Chairman of the Board;
with copies (which shall not constitute notice) to:
Clayton, Dubilier & Rice, LLC
375 Park Avenue, 18th Floor
New York, New York 10152
Attention: Ravi Sachdev
Fax: (212) 407-5252
E-mail: RSachdev@cdr-inc.com
Debevoise & Plimpton
919 Third Avenue
New York, NY 10022
Attention: Meir Katz, Esq.
Fax: (212) 521-7615
E-mail: mdkatz@debevoise.com
Any such notices shall be deemed to be given on the date personally delivered or such return receipt is issued.
9. | Executives Representation |
(a) The Executive hereby represents and warrants to Parent and the Company that the Executive has carefully reviewed this Agreement and has consulted with such advisors as the Executive considers appropriate in connection with this Agreement, and is not subject to any covenants, agreements or restrictions, including without limitation any covenants, agreements or restrictions arising out of the Executives prior employment, which would be breached or violated by Executives execution of this Agreement or by the Executives performance of his duties hereunder.
(b) In addition, the Executive hereby represents, warrants and covenants to Parent and the Company that, other than the Approved Outside Interests or as permitted by Section 2(d), as of the date hereof, he does not have and during the Term of Employment he will not have any professional relationships with (whether as an employee, director, officer, consultant or advisor, and whether or not for compensation) or commitments to any individual or entity (other than Parent and the Company) that operates or conducts (or, to the Executives knowledge, intends to operate or conduct) any business of the types in which Parent, the Company, or any of their respective subsidiaries or their affiliated independent physician associations or physician practices with which any of them has a contractual relationship are engaged.
11
10. | Other Matters |
The Executive agrees and acknowledges that the obligations owed to the Executive under this Agreement are solely the obligations of the Company and Parent, and that none of the stockholders, directors, officers, affiliates, representatives, agents or lenders of or to Company or Parent will have any obligations or liabilities in respect of this Agreement and the subject matter hereof, to the extent allowed by law.
11. | Partial Invalidity; Severability |
In case any one or more of the provisions or parts of a provision contained in this Agreement shall, for any reason, be held to be invalid, illegal or unenforceable in any respect in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision or part of a provision of this Agreement or any other jurisdiction, but this Agreement shall be reformed and construed in any such jurisdiction as if such invalid or illegal or unenforceable provision or part of a provision had never been contained herein and such provision or part shall be reformed so that it would be valid, legal and enforceable to the maximum extent permitted in such jurisdiction.
12. | Waiver of Breach; Specific Performance |
The waiver by the Company, Parent or the Executive of a breach of any provision of this Agreement by the other party shall not operate or be construed as a waiver of any other breach of any party. Each of the parties to this Agreement will be entitled to enforce its respective rights under this Agreement and to exercise all other rights existing in its favor. In the event either party takes legal action to enforce any of the terms or provisions of this Agreement, the nonprevailing party shall pay the successful partys costs and expenses, including but not limited to, attorneys fees, incurred in such action.
13. | Assignment |
Neither the Executive on the one hand, nor the Company or Parent on the other hand, may assign, transfer, pledge, hypothecate, encumber or otherwise dispose of this Agreement or any of his or its respective rights or obligations hereunder without the prior written consent of the other, provided that the Company may assign its rights and obligations under this Agreement to Parent or another wholly-owned subsidiary of Parent that employs members of Parents or the Companys senior management.
12
14. | Amendment; Entire Agreement |
This Agreement may not be changed orally but only by an agreement in writing agreed to by the party against whom enforcement of any waiver, change, modification, extension or discharge is sought. This Agreement and the Equity Documentation embody the entire agreement and understanding of the parties hereto in respect of the subject matter of this Agreement, and supersede and replace all prior agreements, understandings and commitments with respect to such subject matter.
15. | Governing Law; Choice of Forum |
THIS AGREEMENT SHALL BE GOVERNED BY, CONSTRUED, APPLIED AND ENFORCED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF DELAWARE. IN THE EVENT ANY PARTY TO THIS AGREEMENT COMMENCES ANY LITIGATION, PROCEEDING OR OTHER LEGAL ACTION IN CONNECTION WITH OR RELATING TO THIS AGREEMENT, ANY RELATED AGREEMENT OR ANY MATTERS DESCRIBED OR CONTEMPLATED HEREIN OR THEREIN, THE PARTIES TO THIS AGREEMENT HEREBY (1) AGREE UNDER ALL CIRCUMSTANCES ABSOLUTELY AND IRREVOCABLY TO INSTITUTE ANY LITIGATION, PROCEEDING OR OTHER LEGAL ACTION IN A COURT OF COMPETENT JURISDICTION LOCATED WITHIN THE CENTRAL DISTRICT OF CALIFORNIA, WHETHER A STATE OR FEDERAL COURT; (2) AGREE THAT IN THE EVENT OF ANY SUCH LITIGATION, PROCEEDING OR ACTION, SUCH PARTIES WILL CONSENT AND SUBMIT TO THE PERSONAL JURISDICTION OF ANY SUCH COURT DESCRIBED IN CLAUSE (1) OF THIS SECTION AND TO SERVICE OF PROCESS UPON THEM IN ACCORDANCE WITH THE RULES AND STATUTES GOVERNING SERVICE OF PROCESS (IT BEING UNDERSTOOD THAT NOTHING IN THIS SECTION SHALL BE DEEMED TO PREVENT ANY PARTY FROM SEEKING TO REMOVE ANY ACTION TO A FEDERAL COURT IN THE CENTRAL DISTRICT OF CALIFORNIA); (3) IRREVOCABLY CONSENT TO THE SERVICE OF ANY AND ALL PROCESS IN ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT TO SUCH PARTY AT SUCH PARTYS ADDRESS SPECIFIED IN SECTION 8; (4) AGREE TO WAIVE TO THE FULLEST EXTENT PERMITTED BY LAW ANY OBJECTION THAT THEY MAY NOW OR HEREAFTER HAVE TO THE VENUE OF ANY SUCH LITIGATION, PROCEEDING OR ACTION IN ANY SUCH COURT OR THAT ANY SUCH LITIGATION, PROCEEDING OR ACTION WAS BROUGHT IN ANY INCONVENIENT FORUM; AND (5) AGREE, AFTER CONSULTATION WITH COUNSEL, TO WAIVE ANY RIGHTS TO A JURY TRIAL TO RESOLVE ANY DISPUTES OR CLAIMS RELATING TO THIS AGREEMENT. THE CHOICE OF FORUM SET FORTH IN THIS SECTION 15 SHALL NOT BE DEEMED TO PRECLUDE THE ENFORCEMENT OF ANY ACTION UNDER THIS AGREEMENT IN ANY OTHER JURISDICTION.
13
16. | Further Action |
The Executive, the Company and Parent agree to perform any further acts and to execute and deliver any documents which may he reasonable to carry out the provisions hereof.
17. | Counterparts |
This Agreement may be executed in counterparts, including facsimiles, .pdf or other electronic transmission thereof, each of which shall be deemed an original, but all of which together shall constitute one and the same agreement.
18. | Payments by Subsidiaries |
The Executive acknowledges that one or more payments hereunder may be paid by one or more of the Parents or the Companys subsidiaries, and the Executive agrees that any such payment made by such subsidiary shall satisfy the obligations of Parent and the Company hereunder with respect to (but only to the extent of) such payment.
19. | Tax Matters |
The Executive acknowledges that the payments and benefits provided under the terms of this Agreement shall constitute taxable income to the extent provided in the applicable provisions of the United States Internal Revenue Code of 1986, as amended, and any successor thereto and applicable regulations thereunder (the Code) and other applicable tax laws. Moreover, the Executive understands and acknowledges that Parent and the Company have not provided any advice regarding his tax liability resulting from this Agreement and that he has been advised to consult with his personal tax advisor or legal counsel as to the taxability of the payments and benefits provided under this Agreement, including the equity investment and awards provided under Section 5. The Executive shall be solely responsible for taxes imposed on him by reason of any payments or benefits provided under this Agreement and all such payments and benefits shall be subject to applicable federal, state, local and foreign withholding requirements. All payments to be made or benefits to be provided to the Executive pursuant to this Agreement shall be made net of all applicable income and employment taxes required to be withheld from such payments pursuant to any applicable law or regulation.
14
20. | Applicability of Section 409A of the Code |
To the extent that any reimbursement, fringe benefit or other, similar plan or arrangement in which the Executive participates during the term of the Executives employment under this Agreement or thereafter provides for a deferral of compensation within the meaning of Section 409A of the Code, (i) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, (ii) the amount eligible for reimbursement or payment under such plan or arrangement in one calendar year may not affect the amount eligible for reimbursement or payment in any other calendar year (except that a plan providing medical or health benefits may impose a generally applicable limit on the amount that may be reimbursed or paid), (iii) subject to any shorter time periods provided in any expense reimbursement policy of the Company, any reimbursement or payment of an expense under such plan or arrangement must be made on or before the last day of the calendar year following the calendar year in which the expense was incurred and (iv) the reimbursements shall be made pursuant to objectively determinable and nondiscretionary Company policies and procedures regarding such reimbursement of expenses. In addition, with respect to any payments or benefits subject to Section 409A of the Code, reference to the Executives termination of employment (and corollary terms) with the Company shall be construed to refer to the Executives separation from service (as determined under Treas. Reg. Section 1.409A-1(h), as uniformly applied by the Company) with the Company. Whenever a provision under this Agreement specifies a payment period with reference to a number of days, the actual date of payment within the specified period shall be within the sole discretion of the Company. The Executives right to receive any installment payments hereunder shall, for purposes of Section 409A, be treated as a right to receive a series of separate and distinct payments. If the timing of the Executives execution of a general release of claims pursuant to Section 3(i) could impact the calendar year in which any payment under this Agreement that is subject to Section 409A of the Code will be made, such payment will be made in the later calendar year.
Notwithstanding anything to the contrary in this Agreement, if the Executive is a specified employee within the meaning of Section 409A of the Code at the time of the Executives separation from service (other than due to death), then any payment under this Agreement that is subject to Section 409A of the Code and that is payable by reason of the Executives separation from service within the first six months following the Executives separation from service will become payable on the first payroll date that occurs on or after the date six months and one day following the date of the Executives separation from service. All subsequent related payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit. Notwithstanding anything herein to the contrary, if the Executive dies following the Executives separation from service, but prior to the six month anniversary of the separation from service, then any payments delayed in accordance with this paragraph will be payable in a lump sum as soon as administratively practicable after the date of the Executives death and all other related payments will be payable in accordance with the payment schedule applicable to each payment or benefit.
The foregoing provisions are intended to comply with the requirements of Section 409A of the Code so that none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A of the Code, and, if any ambiguity is found herein with respect to such payments or benefits, any such ambiguities will be interpreted to so comply. If any payment or benefits subject to Section 409A of the Code could be construed not to comply with Section 409A of the
15
Code, the Company and the Executive agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to the Executive under Section 409A of the Code.
21. | D&O Insurance |
Parent shall cause the Executive to both during the Term of Employment and thereafter be covered by directors and officers liability insurance to the same extent that such coverage is then maintained for officers or directors of Parent or the Company in active service, and any tail policy providing directors and officers liability coverage that covers a period of service in which the Executive is or was in active service shall cover the Executives employment or service with Parent and the Company for a similar period. Parent shall use commercially reasonable efforts to obtain the insurance described in this Section 21.
22. | Indemnification |
The Company and Parent agree to indemnify the Executive and hold the Executive harmless to the fullest extent permitted by applicable law and Parents and the Companys organizational documents from and against any and all actual or threatened third-party claims, demands, penalties, suits, proceedings or actions (whether civil, criminal, administrative or investigative) where such actual or threatened claims, demands, penalties, suits, proceedings or actions are brought or made against the Executive based on any alleged act or failure to act related in any way to the Executives services as an officer, employee or director of Parent or the Company, and from any and all judgments, fines, settlements, losses, costs, expenses and other amounts actually and reasonably incurred in connection therewith, including attorneys fees, where such claim, loss or liability is by reason of the fact that the Executive is or was an officer, director, employee or agent of the Company or Parent, except, in each case, to the extent arising from gross negligence, willful misconduct or material breach of this Agreement by the Executive. Notwithstanding the foregoing, in connection with any indemnification provided by this Section 22, the Executive shall engage and use legal counsel reasonably acceptable to Parent and the Company, subject to such reasonable substantiation and documentation as may be specified by Parent or the Company, and the Executive shall not agree to the settlement of any such matter without the express written approval of Parent or the Company. In addition, Parents and the Companys obligations under this Section 22 are secondary to any valid and collectible insurance that applies to the Executive.
16
23. | Confidential Terms |
Except as required by applicable law, Executive agrees not to disclose the terms of this Agreement to any person or entity, other than Executives attorneys, accountants, financial advisors, or members of Executives immediate family who need to know this information and agree to keep it confidential.
[Signature Page Follows]
17
IN WITNESS WHEREOF, this Agreement has been executed as of the date first written above.
EXECUTIVE | ||
/s/ Steven J. Sell | ||
Name: | Steven J. Sell | |
AGILON HEALTH, INC. | ||
/s/ Ravi Sachdev | ||
Name: | Ravi Sachdev | |
Title: | President | |
AGILON HEALTH TOPCO, INC. | ||
/s/ Ravi Sachdev | ||
Name: | Ravi Sachdev | |
Title: | President |
18